FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209348535> ?p ?o ?g. }

• W3209348535 endingPage "108302" @default.
• W3209348535 startingPage "108302" @default.
• W3209348535 abstract "Cervical cancer is the fourth most common malignant tumor in the world, for advanced cervical cancer, more than 30% of patients continue to have tumor and relapse or metastasis after the traditional treatment (concurrent chemoradiotherapy), and the response rate of immune checkpoint inhibitor (PD-1) is less 15%, so additional approaches are required. In situ vaccine is a very promising immunotherapy strategy. In the preclinical study, the combination of CPG and anti-Ox40 antibody can completely resolve injection site tumours and distant tumours and leads to the recovery of most mice with lymphoma. However, our early exploration process found that the effect of CpG + OX40 in the treatment of advanced cervical cancer is not ideal. Hence, we explored the anti-tumor effect of CpG + OX40 combined with anti-angiogenic therapy for the first time. The results showed that the combination significantly inhibited the proliferation of primary and secondary tumor volume and prolonged the survival time of mice, compared with the control group, CD3+, CD4 + and CD8 + T cells in the combined group showed an increasing trend. In addition, in terms of metabolism, the anti-vascular effect of anlotinib can significantly reduce the blood supply and metabolic level of tumor, the expression of Ki67 and CD31 in the control group was significantly higher than that in each administration group. In conclusion, our preclinical research results showed that the combination of in situ vaccine and anti-angiogenic therapy has a good anti-tumor effect, and may potentially offer an effective treatment option for patients with advanced cervical cancer." @default.
• W3209348535 created "2021-11-08" @default.
• W3209348535 creator A5010968379 @default.
• W3209348535 creator A5016650205 @default.
• W3209348535 creator A5020368922 @default.
• W3209348535 creator A5022284544 @default.
• W3209348535 creator A5023478078 @default.
• W3209348535 creator A5024252338 @default.
• W3209348535 creator A5033179664 @default.
• W3209348535 creator A5034998180 @default.
• W3209348535 creator A5060668984 @default.
• W3209348535 creator A5072226386 @default.
• W3209348535 creator A5082985248 @default.
• W3209348535 creator A5090074970 @default.
• W3209348535 date "2021-12-01" @default.
• W3209348535 modified "2023-10-16" @default.
• W3209348535 title "Anti-tumour effect of in situ vaccines combined with VEGFR inhibitors in the treatment of metastatic cervical cancer" @default.
• W3209348535 cites W1897491859 @default.
• W3209348535 cites W1978146796 @default.
• W3209348535 cites W1984075836 @default.
• W3209348535 cites W1992112921 @default.
• W3209348535 cites W2011912935 @default.
• W3209348535 cites W2071875829 @default.
• W3209348535 cites W2073310925 @default.
• W3209348535 cites W2073727431 @default.
• W3209348535 cites W2080202443 @default.
• W3209348535 cites W2089551334 @default.
• W3209348535 cites W2100756525 @default.
• W3209348535 cites W2105357534 @default.
• W3209348535 cites W2109347785 @default.
• W3209348535 cites W2117692326 @default.
• W3209348535 cites W2122888213 @default.
• W3209348535 cites W2131778873 @default.
• W3209348535 cites W2134060682 @default.
• W3209348535 cites W2138733343 @default.
• W3209348535 cites W2154502317 @default.
• W3209348535 cites W2171986697 @default.
• W3209348535 cites W2237699600 @default.
• W3209348535 cites W2508403025 @default.
• W3209348535 cites W2601414401 @default.
• W3209348535 cites W2605792367 @default.
• W3209348535 cites W2746357202 @default.
• W3209348535 cites W2786472249 @default.
• W3209348535 cites W2808601843 @default.
• W3209348535 cites W2886339021 @default.
• W3209348535 cites W2902847183 @default.
• W3209348535 cites W2914703963 @default.
• W3209348535 cites W2924289105 @default.
• W3209348535 cites W2963305393 @default.
• W3209348535 cites W2981790403 @default.
• W3209348535 cites W3004264565 @default.
• W3209348535 cites W3012207340 @default.
• W3209348535 cites W3025022288 @default.
• W3209348535 cites W3033218405 @default.
• W3209348535 cites W3037919768 @default.
• W3209348535 cites W3128646645 @default.
• W3209348535 cites W4232939899 @default.
• W3209348535 cites W631082517 @default.
• W3209348535 doi "https://doi.org/10.1016/j.intimp.2021.108302" @default.
• W3209348535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34717193" @default.
• W3209348535 hasPublicationYear "2021" @default.
• W3209348535 type Work @default.
• W3209348535 sameAs 3209348535 @default.
• W3209348535 citedByCount "0" @default.
• W3209348535 crossrefType "journal-article" @default.
• W3209348535 hasAuthorship W3209348535A5010968379 @default.
• W3209348535 hasAuthorship W3209348535A5016650205 @default.
• W3209348535 hasAuthorship W3209348535A5020368922 @default.
• W3209348535 hasAuthorship W3209348535A5022284544 @default.
• W3209348535 hasAuthorship W3209348535A5023478078 @default.
• W3209348535 hasAuthorship W3209348535A5024252338 @default.
• W3209348535 hasAuthorship W3209348535A5033179664 @default.
• W3209348535 hasAuthorship W3209348535A5034998180 @default.
• W3209348535 hasAuthorship W3209348535A5060668984 @default.
• W3209348535 hasAuthorship W3209348535A5072226386 @default.
• W3209348535 hasAuthorship W3209348535A5082985248 @default.
• W3209348535 hasAuthorship W3209348535A5090074970 @default.
• W3209348535 hasBestOaLocation W32093485351 @default.
• W3209348535 hasConcept C121608353 @default.
• W3209348535 hasConcept C126322002 @default.
• W3209348535 hasConcept C143998085 @default.
• W3209348535 hasConcept C167672396 @default.
• W3209348535 hasConcept C203014093 @default.
• W3209348535 hasConcept C2776999253 @default.
• W3209348535 hasConcept C2777701055 @default.
• W3209348535 hasConcept C2778220009 @default.
• W3209348535 hasConcept C2778424827 @default.
• W3209348535 hasConcept C2779013556 @default.
• W3209348535 hasConcept C2780674031 @default.
• W3209348535 hasConcept C502942594 @default.
• W3209348535 hasConcept C71924100 @default.
• W3209348535 hasConcept C8891405 @default.
• W3209348535 hasConceptScore W3209348535C121608353 @default.
• W3209348535 hasConceptScore W3209348535C126322002 @default.
• W3209348535 hasConceptScore W3209348535C143998085 @default.
• W3209348535 hasConceptScore W3209348535C167672396 @default.
• W3209348535 hasConceptScore W3209348535C203014093 @default.
• W3209348535 hasConceptScore W3209348535C2776999253 @default.

• next